Evidence map›Paper›PMID 29402958›Full record

ArticleNature communications2018

Cell fate in antiviral response arises in the crosstalk of IRF, NF-κB and JAK/STAT pathways.

Maciej Czerkies, Zbigniew Korwek, Wiktor Prus, Marek Kochańczyk, Joanna Jaruszewicz-Błońska, Karolina Tudelska, Sławomir Błoński, Marek Kimmel, Allan R Brasier, Tomasz Lipniacki

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Chronic airway inflammation inFrontiers in immunology · 2025
    Article
  10. A20 as a Potential Therapeutic Target for COVID-19.Immunity, inflammation and disease · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Maciej CzerkiesInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
Zbigniew KorwekInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
Wiktor PrusInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
Marek KochańczykInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.ORCID http://orcid.org/0000-0003-1215-3920
Joanna Jaruszewicz-BłońskaInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
Karolina TudelskaInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
Sławomir BłońskiInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland.
Marek KimmelDepartments of Statistics and Bioengineering, and Program in Systems, Synthetic, and Physical Biology, Rice University, Houston, TX, 77005, USA.
Allan R BrasierInstitute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, 77555-1060, USA.ORCID http://orcid.org/0000-0002-5012-4090
Tomasz LipniackiInstitute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, 02-106, Poland. tlipnia@ippt.pan.pl.ORCID http://orcid.org/0000-0002-3488-2561
Institute of Fundamental Technological Research · PLSilesian University of Technology · PLThe University of Texas Medical Branch at Galveston · US

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
Virus, Tissue Culture and ImmunoassayP01AI062885 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI GAROFALO, ROBERTO P · 2005 to 2022
$23.9M
Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
NCATS NIH HHS UL1 TR001439NIAID NIH HHS P01 AI062885NIEHS NIH HHS P30 ES006676
6 · The paper itself

Abstract

The innate immune system processes pathogen-induced signals into cell fate decisions. How information is turned to decision remains unknown. By combining stochastic mathematical modelling and experimentation, we demonstrate that feedback interactions between the IRF3, NF-κB and STAT pathways lead to switch-like responses to a viral analogue, poly(I:C), in contrast to pulse-like responses to bacterial LPS. Poly(I:C) activates both IRF3 and NF-κB, a requirement for induction of IFNβ expression. Autocrine IFNβ initiates a JAK/STAT-mediated positive-feedback stabilising nuclear IRF3 and NF-κB in first responder cells. Paracrine IFNβ, in turn, sensitises second responder cells through a JAK/STAT-mediated positive feedforward pathway that upregulates the positive-feedback components: RIG-I, PKR and OAS1A. In these sensitised cells, the 'live-or-die' decision phase following poly(I:C) exposure is shorter-they rapidly produce antiviral responses and commit to apoptosis. The interlinked positive feedback and feedforward signalling is key for coordinating cell fate decisions in cellular populations restricting pathogen spread.

Indexed as

2',5'-Oligoadenylate SynthetaseAnimalsCell LineDEAD Box Protein 58eIF-2 KinaseFeedback, PhysiologicalGene Knockout TechniquesImmunity, InnateInterferon-betaInterferon InducersInterferon Regulatory Factor-3Janus KinasesMiceNF-kappa BPoly I-CSignal Transduction2',5'-Oligoadenylate SynthetaseDdx58 protein, mouseDEAD Box Protein 58eIF-2 KinaseInterferon-betaInterferon InducersInterferon Regulatory Factor-3Irf3 protein, mouseJanus KinasesNF-kappa BPoly I-CRela protein, mouseStat1 protein, mouseSTAT1 Transcription FactorSTAT Transcription FactorsTranscription Factor RelA

Identifiers

PMID29402958
PMCPMC5799375
OpenAlexW2802933453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.